Found: 25
Select item for more details and to access through your institution.
How comparable are patient outcomes in the "real-world" with populations studied in pivotal AML trials?
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-00996-x
- By:
- Publication type:
- Article
scTEM-seq: Single-cell analysis of transposable element methylation to link global epigenetic heterogeneity with transcriptional programs.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-09765-x
- By:
- Publication type:
- Article
NETosis and thrombosis in vaccine-induced immune thrombotic thrombocytopenia.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-32946-1
- By:
- Publication type:
- Article
A comparative evaluation of three consecutive artificial intelligence algorithms released by Techcyte for identification of blasts and white blood cells in abnormal peripheral blood films.
- Published in:
- International Journal of Laboratory Hematology, 2024, v. 46, n. 1, p. 92, doi. 10.1111/ijlh.14180
- By:
- Publication type:
- Article
White blood cell evaluation in haematological malignancies using a web‐based digital microscopy platform.
- Published in:
- International Journal of Laboratory Hematology, 2021, v. 43, n. 6, p. 1379, doi. 10.1111/ijlh.13657
- By:
- Publication type:
- Article
Genomic investigation of inherited thrombotic microangiopathy—aHUS and TTP.
- Published in:
- International Journal of Laboratory Hematology, 2020, v. 42, p. 33, doi. 10.1111/ijlh.13201
- By:
- Publication type:
- Article
Transfusion‐associated circulatory overload in ambulatory patients.
- Published in:
- Vox Sanguinis, 2019, v. 114, n. 3, p. 216, doi. 10.1111/vox.12753
- By:
- Publication type:
- Article
Targeting Oncogenic Signaling in Mutant FLT3 Acute Myeloid Leukemia: The Path to Least Resistance.
- Published in:
- International Journal of Molecular Sciences, 2018, v. 19, n. 10, p. 3198, doi. 10.3390/ijms19103198
- By:
- Publication type:
- Article
Combining 5‐azacitidine with the E‐selectin antagonist uproleselan is an effective strategy to augment responses in myelodysplasia and acute myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 6, p. 2264, doi. 10.1111/bjh.19466
- By:
- Publication type:
- Article
Crosstalk between DNA methylation and hypoxia in acute myeloid leukaemia.
- Published in:
- Clinical Epigenetics, 2023, v. 15, n. 1, p. 1, doi. 10.1186/s13148-023-01566-x
- By:
- Publication type:
- Article
Australia and New Zealand consensus position statement: use of COVID‐19 therapeutics in patients with haematological malignancies.
- Published in:
- Internal Medicine Journal, 2024, v. 54, n. 2, p. 328, doi. 10.1111/imj.16303
- By:
- Publication type:
- Article
Updated treatment options for immune thrombocytopenia.
- Published in:
- Internal Medicine Journal, 2024, v. 54, n. 2, p. 201, doi. 10.1111/imj.16246
- By:
- Publication type:
- Article
COVID‐19 vaccination in haematology patients: an Australian and New Zealand consensus position statement.
- Published in:
- Internal Medicine Journal, 2021, v. 51, n. 5, p. 763, doi. 10.1111/imj.15247
- By:
- Publication type:
- Article
High Expression of ENO1 and Low Levels of Circulating Anti-ENO1 Autoantibodies in Patients with Myelodysplastic Neoplasms and Acute Myeloid Leukaemia.
- Published in:
- Cancers, 2024, v. 16, n. 5, p. 884, doi. 10.3390/cancers16050884
- By:
- Publication type:
- Article
Unravelling the Epigenome of Myelodysplastic Syndrome: Diagnosis, Prognosis, and Response to Therapy.
- Published in:
- Cancers, 2020, v. 12, n. 11, p. 3128, doi. 10.3390/cancers12113128
- By:
- Publication type:
- Article
Targeting Apoptotic Pathways in Acute Myeloid Leukaemia.
- Published in:
- Cancers, 2019, v. 11, n. 11, p. 1660, doi. 10.3390/cancers11111660
- By:
- Publication type:
- Article
Healthcare resource utilization trends in patients with acute myeloid leukemia ineligible for intensive chemotherapy receiving first‐line systemic treatment or best supportive care: A multicenter international study.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 1, p. 58, doi. 10.1111/ejh.13769
- By:
- Publication type:
- Article
Serum Free Light Chain Kinetics Is Predictive of Renal Response in Myeloma Patients With Renal Impairment--An ALLG Trial of Carfilzomib-Dexamethasone Therapy in Frontline and Relapse.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 8, p. 543, doi. 10.1016/j.clml.2024.04.001
- By:
- Publication type:
- Article
Zeroing in on red blood cell unit expiry.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Consensus guidelines for the management of adult immune thrombocytopenia in Australia and New Zealand.
- Published in:
- Medical Journal of Australia, 2022, v. 216, n. 1, p. 43, doi. 10.5694/mja2.51284
- By:
- Publication type:
- Article
Diagnosis and management of heparin-induced thrombocytopenia: a consensus statement from the Thrombosis and Haemostasis Society of Australia and New Zealand HIT Writing Group.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Primary lymphoma of the uterus and cervix: two case reports and review of the literature.
- Published in:
- Australian & New Zealand Journal of Obstetrics & Gynaecology, 2011, v. 51, n. 6, p. 559, doi. 10.1111/j.1479-828X.2011.01365.x
- By:
- Publication type:
- Article
Certainty in uncertainty: Determining the rate and reasons for reclassification of variants of uncertain significance in haematological malignancies.
- Published in:
- EJHaem, 2024, v. 5, n. 5, p. 957, doi. 10.1002/jha2.1002
- By:
- Publication type:
- Article
Development of the treatment preference in myelodysplasia questionnaire for clinicians, carers, and patients.
- Published in:
- EJHaem, 2024, v. 5, n. 3, p. 535, doi. 10.1002/jha2.930
- By:
- Publication type:
- Article
Real‐world study of the use of azacitidine in myelodysplasia in Australia.
- Published in:
- EJHaem, 2024, v. 5, n. 3, p. 527, doi. 10.1002/jha2.911
- By:
- Publication type:
- Article